MLP SE (MLP)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 10.82 |
|---|---|
| 52-week range | 5.85 – 11.20 |
| Return, 1 month / 3 months | +13.9% / +44.5% |
| Return, 1 year / 3 years | +56.1% / +177.2% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 25.7% |
| Worst drawdown (1 year) | -15.0% |
| Average daily value traded | 1.02M EUR |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MLP SE is a German financial advisory group that serves private households and businesses. Its advisers help clients with insurance, health cover, retirement provision, investment and wealth management, and financing questions. The firm works mainly through its own network of consultants and offices across Germany, and it also provides advice to small and medium-sized companies on employee benefits and corporate pension arrangements. MLP is based in Wiesbaden, Germany.
On this site MLP SE appears as a stock on the XETRA Stock Exchange (Germany), code MLP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MLP SE (MLP) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 10.82 on 22 October 2026.
Its price-based Market X-Ray is 84 out of 100 (a strong price profile), ranking 7 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 56.1% and over the last three months it rose 44.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 37.5% | ||
| From 52-week high | -2.7% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 44.5% | ||
| 6-month return | 47.3% | ||
| 12-month return, skipping the last month | 37.0% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.0% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 1.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.4% |
|---|---|
| 1 month | +13.9% |
| 3 months | +44.5% |
| 6 months | +47.3% |
| 1 year | +56.1% |
| 3 years | +177.2% |
| 5 years | +62.9% |
Signals
| 50-day / 200-day average | 9.64 / 7.87 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | EUR 0.3600 |
| 26 Jun 2025 | EUR 0.3600 |
| 28 Jun 2024 | EUR 0.3000 |
| 30 Jun 2023 | EUR 0.3000 |
| 3 Jun 2022 | EUR 0.3000 |
| 25 Jun 2021 | EUR 0.2300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.